Nektar Therapeutics capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.25x
Net debt / equity: 0.02x
Debt / assets: 0.19x
Debt / EBITDA: -1.14x
Net debt / EBITDA: -0.09x

Liquidity & coverage

Current ratio: 10.21x
Quick ratio: 10.21x
Cash ratio: 9.85x
Interest coverage: -4.29x
EBITDA / interest: -4.32x
Working capital: $531.3M

Cash & dividend

FCF / debt: -1.42x
Cash flow / debt: -1.42x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.